Nēsos Revenue and Competitors
Estimated Revenue & Valuation
- Nēsos's estimated annual revenue is currently $807.3k per year.
- Nēsos's estimated revenue per employee is $62,100
- Nēsos's total funding is $16.5M.
Employee Data
- Nēsos has 13 Employees.
- Nēsos grew their employee count by -13% last year.
Nēsos's People
Name | Title | Email/Phone |
---|
Nēsos Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.3M | 57 | 16% | N/A | N/A |
#2 | $179.6M | 435 | -1% | N/A | N/A |
#3 | $6.5M | 28 | 12% | N/A | N/A |
#4 | $5.3M | 21 | -9% | N/A | N/A |
#5 | $12.4M | 50 | 19% | N/A | N/A |
#6 | $13.6M | 46 | 0% | N/A | N/A |
#7 | $6.5M | 23 | -8% | N/A | N/A |
#8 | $18M | 71 | 16% | N/A | N/A |
#9 | $10.2M | 47 | 2% | N/A | N/A |
#10 | $181.6M | 476 | 7% | N/A | N/A |
What Is Nēsos?
Leveraging neuroscience research, Nēsos aims to treat diseases, by restoring neurological pathways that control immune function. Purpose designed earbuds non invasively deliver engineered neural input to activate target brain pathways.
keywords:N/A$16.5M
Total Funding
13
Number of Employees
$807.3k
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nēsos News
2020-12-10 - Nēsos Closes $16.5M To Develop Rheumatoid Arthritis Earbud
24 Shares Email Facebook Twitter LinkedIn Nēsos launched out of stealth Thursday and is poised to commercialize a new method for the treatment of rheumatoid arthritis. It raised $16.5 million in funding, led by Mayfield Fund, 1 to continue its clinical trials. Subscribe to the Crunchbase Daily ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 13 | 0% | N/A |
#2 | $3.5M | 13 | -19% | N/A |
#3 | $3.1M | 13 | -19% | N/A |
#4 | $2.6M | 13 | 30% | N/A |
#5 | $1.2M | 13 | 0% | N/A |